Nanoscope Therapeutics begins rolling submission of BLA to US FDA for gene-agnostic therapy, MCO-010 to treat retinitis pigmentosa: Dallas, Texas Wednesday, July 16, 2025, 14:30 H ...

TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), is expanding its ophthalmology business unit with new leadership talent and enhanced delivery capabilities to meet risin ...

Investors say genetic prediction services for embryos, used by Elon Musk and others, are a trust fund for future children.

If you have daily living and/or mobility needs due to a sight condition or low vision, you might be eligible for PIP or ADP ...